Does continuous subcutaneous insulin infusion (CSII) result in improved glycemic control compared to multiple daily injections (MDI) in children and adolescents with type 1 diabetes?
Role: Reviewer
In adults with type 1 diabetes, does continuous subcutaneous insulin infusion (CSII) result in better glycemic control compared to multiple daily injections (MDI)?
In individuals with type 1 diabetes does continuous subcutaneous insulin infusion (CSII) result in a decreased frequency of hypoglycemia compared to multiple daily injections (MDI)?
Does continuous subcutaneous insulin infusion (CSII) result in improved quality of life compared to multiple daily injections (MDI) for children and adolescents with type 1 diabetes?
In adults with type 1 diabetes does continuous subcutaneous insulin infusion (CSII) result in improved quality of life compared to multiple daily injections (MDI)?
In pregnancy complicated by diabetes, does continuous subcutaneous insulin infusion (CSII) result in improved glycemic control compared to multiple daily injections (MDI)?
In individuals with type 2 diabetes, does continuous subcutaneous insulin infusion (CSII) result in better glycemic control compared to multiple daily injections (MDI)?
Diabetes - Continuous Subcutaneous Insulin Infusion Background
View Resource